Contributions of PrimarySrcPatia

Contributions by PrimarySrcPatia, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 733 edits includes activity predating the current log.

1. 18:28, 1 Jul 2026 (diff | hist) Qingdao Saber Technology Pharmaceutical 11,956 ±0 promote subsection to section
2. 14:33, 17 Jun 2026 (diff | hist) Qingdao Sigma Chemical 12,284 ±0 de-orphan
3. 19:37, 13 Jun 2026 (diff | hist) WuXi TIDES 13,269 ±0 rv promotional edit
4. 09:33, 5 Jun 2026 (diff | hist) Talk:Tianjin Finder Chemical 959 +189 /* Is "no storage-interval confound" a favourable statement? */ reply
5. 09:38, 14 May 2026 (diff | hist) Talk:Sangon Biotech 959 +235 /* Comparing documentation within one organisation */ reply
6. 05:16, 6 May 2026 (diff | hist) Qingdao Saber Technology Pharmaceutical 11,956 ±0 m fix arithmetic in worked example
7. 10:35, 14 Apr 2026 (diff | hist) GL Biochem (Shanghai) 13,879 ±0 clarify whether figure is gross or net mass
8. 07:43, 15 Mar 2026 (diff | hist) Shanghai ERP Biotechnology 11,516 ±0 m rm citation to a supplier's own page
9. 15:12, 2 Mar 2026 (diff | hist) Talk:Peptide stability table 1,244 +272 /* Sourcing of the reconstituted-stability column */ reply
10. 19:50, 27 Feb 2026 (diff | hist) Guangzhou JEEP Biotechnology 12,891 ±0 split section
11. 08:43, 13 Feb 2026 (diff | hist) Shanghai Wibson Biotechnology 11,996 ±0 m typo
12. 18:59, 5 Feb 2026 (diff | hist) WuXi TIDES 13,269 ±0 m add hatnote
13. 00:10, 18 Jan 2026 (diff | hist) Bachem Holding (Suzhou) 12,136 ±0 m state the assay for the reference interval
14. 08:02, 9 Nov 2025 (diff | hist) Shanghai Wibson Biotechnology 10,152 +303 merge two short sections
15. 04:35, 18 Oct 2025 (diff | hist) Wuhan Wansheng Biotechnology 12,543 ±0 state the assay for the reference interval
16. 21:13, 18 Sep 2025 (diff | hist) GL Biochem (Shanghai) 13,627 ±0 m correct transposed digits
17. 09:33, 7 Sep 2025 (diff | hist) Bachem Holding (Suzhou) 11,425 ±0 m correct transposed digits
18. 02:56, 18 Aug 2025 (diff | hist) Shanghai Sigma-Audley New Material Technology 10,745 ±0 rv unexplained removal of sourced content
19. 18:41, 16 Aug 2025 (diff | hist) Xi'an Mokemei Biotechnology 7,947 ±0 fix significant figures — source gives fewer
20. 17:46, 12 Aug 2025 (diff | hist) ChinaPeptides 10,349 +207 fix arithmetic in worked example
21. 11:26, 4 Aug 2025 (diff | hist) Xi'an Mokemei Biotechnology 7,580 +27 copyedit
22. 04:40, 31 Jul 2025 (diff | hist) Nantong Guangyuan Chemical 10,177 ±0 lead should summarise the body, not add to it
23. 06:38, 29 Jul 2025 (diff | hist) Hubei Jianxiang Bioscience 6,978 ±0 m add DOI
24. 09:31, 15 Jul 2025 (diff | hist) Talk:Shanghai Sigma-Audley New Material Technology 959 +274 /* Documentation gradient across the catalogue */ reply
25. 16:18, 22 Jun 2025 (diff | hist) Zhuhai Kerui Biotechnology 4,353 +912 rv promotional edit
26. 02:22, 18 Jun 2025 (diff | hist) Hubei Jianxiang Bioscience 5,346 ±0 m state the assay for the reference interval
27. 01:11, 18 Jun 2025 (diff | hist) Qingdao Saber Technology Pharmaceutical 2,112 ±0 label community tally as self-reported
28. 03:06, 7 Jun 2025 (diff | hist) Hubei Jianxiang Bioscience 5,346 ±0 fix unit
29. 11:35, 3 Apr 2025 (diff | hist) Trial data comparison 3,217 ±0 label community tally as self-reported
30. 16:23, 9 Mar 2025 (diff | hist) Hunan Aslsen Technology 7,073 +74 expand §Product range
31. 23:29, 28 Feb 2025 (diff | hist) Flourishglobal Peptide Biotech 2,131 ±0 rv — see talk
32. 23:19, 31 Dec 2024 (diff | hist) Bachem Holding (Suzhou) 5,455 ±0 correct transposed digits
33. 14:45, 27 Nov 2024 (diff | hist) Bachem Holding (Suzhou) 4,797 ±0 add comparator rate
34. 11:58, 11 Oct 2024 (diff | hist) Bachem Holding (Suzhou) 1,724 +38 consistent en dashes in ranges
35. 06:15, 16 Sep 2024 (diff | hist) Hunan Aslsen Technology 1,699 ±0 add comparator rate
36. 05:27, 29 Aug 2024 (diff | hist) WuXi TIDES 3,040 ±0 clarify whether figure is gross or net mass